IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,296 | -5.4% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $15,108 | -11.1% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | -86.9% | 400 | -88.4% | 0.00% | -83.3% |
| Q2 2022 | $130,000 | -30.5% | 3,435 | -32.2% | 0.01% | -25.0% |
| Q1 2022 | $187,000 | +21.4% | 5,063 | -0.1% | 0.01% | +33.3% |
| Q4 2021 | $154,000 | -4.9% | 5,066 | +4.7% | 0.01% | 0.0% |
| Q3 2021 | $162,000 | -13.4% | 4,838 | +2.8% | 0.01% | -14.3% |
| Q2 2021 | $187,000 | -14.6% | 4,704 | -8.3% | 0.01% | +16.7% |
| Q1 2021 | $219,000 | -9.5% | 5,127 | -10.7% | 0.01% | -40.0% |
| Q4 2020 | $242,000 | +4740.0% | 5,739 | +5639.0% | 0.01% | – |
| Q4 2017 | $5,000 | -77.3% | 100 | -79.2% | 0.00% | -100.0% |
| Q4 2016 | $22,000 | +29.4% | 480 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $17,000 | +54.5% | 480 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $11,000 | -52.2% | 480 | -14.9% | 0.00% | -50.0% |
| Q1 2016 | $23,000 | – | 564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |